• Capecitabine in Preclinical Oncology: Advanced Workflows ...

  2025-10-02

  Discover how Capecitabine, a potent fluoropyrimidine prodrug, is revolutionizing preclinical oncology research through tumor-targeted activation and apoptosis induction. This guide delivers actionable protocols, troubleshooting insights, and highlights Capecitabine’s unique role in cutting-edge assembloid models for improved chemotherapy selectivity.

• Cisapride (R 51619): Precision Tool for Cardiotoxicity an...

  2025-10-01

  Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, uniquely advances both cardiac electrophysiology and gastrointestinal motility research. Gain insights into cutting-edge phenotypic screening strategies and emerging applications that set this compound apart.

• Reengineering the Calcium Signaling Paradigm: Strategic G...

  2025-09-30

  This thought-leadership article explores the mechanistic and translational frontiers of calcium signaling research, focusing on the strategic application of Ruthenium Red as a high-affinity inhibitor of Ca2+ transport. Integrating recent findings on cytoskeleton-dependent mechanotransduction and autophagy, it provides actionable insights for researchers aiming to bridge molecular mechanisms with therapeutic ambitions. The narrative critically evaluates the competitive reagent landscape, highlights unmet needs in inflammation and stress signaling studies, and positions Ruthenium Red as an essential tool for pioneering breakthrough discoveries.

• ABT-737: Advancing Apoptosis Research Through Precision B...

  2025-09-29

  Explore how ABT-737, a potent BCL-2 protein inhibitor, enables targeted apoptosis induction in cancer cells. This article uniquely integrates mechanistic insights with recent discoveries on mitochondrial signaling, revealing advanced research applications beyond current literature.

• 3X (DYKDDDDK) Peptide: Enabling Precision Structural Viro...

  2025-09-28

  Discover how the 3X (DYKDDDDK) Peptide revolutionizes epitope tagging for recombinant protein purification and structural virology. This in-depth analysis uncovers advanced mechanisms—such as calcium-dependent antibody interactions and synergy with host restriction studies—that extend far beyond traditional applications.

• DAPI (hydrochloride): Precision DNA Quantitation in Organ...

  2025-09-27

  Explore the transformative role of DAPI (hydrochloride), a leading fluorescent DNA stain, in high-throughput quantitation and functional genomics of organoid systems. This article reveals advanced applications and workflow innovations that set it apart from conventional approaches.

• Annexin V-FITC/PI Apoptosis Assay Kit: Precision Tools fo...

  2025-09-26

  Explore the Annexin V-FITC/PI Apoptosis Assay Kit for advanced apoptosis detection and cell death pathway analysis in renal cell carcinoma research. This cornerstone article uniquely integrates autophagy-apoptosis crosstalk and cutting-edge insights into tumor biology.

• Sulfo-NHS-Biotin: Enabling High-Throughput Cell Surface P...

  2025-09-25

  Explore the scientific power of Sulfo-NHS-Biotin, a water-soluble biotinylation reagent optimized for advanced cell surface protein labeling and modern high-throughput assays. This article uniquely examines its role in single-cell screening platforms and provides technical insights beyond conventional applications.

• Innovations in mRNA Reporter Technology: EZ Cap™ Firefly ...

  2025-09-24

  Explore how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) revolutionizes bioluminescent reporter assays with enhanced stability, Cap 1 capping, and immune suppression. Discover distinct insights into mechanistic optimization and translational applications not covered in previous articles.

• Rhodamine 123 dye Norepinephrine and epinephrine are catecho

  2025-03-03

  

  Norepinephrine and epinephrine are catecholamines (CA) released from synaptic nerves and the adrenal gland that mediate systemic responses to nutritional stressors (Cannon and De la Paz, 1911). CA mobilize plasma glucose by suppressing insulin secretion from the pancreatic β-cell (Katada and Ui, 198

• Compounds were profiled for their

  2025-03-03

  

  Compounds – were profiled for their inhibitory activity against dipeptidyl peptidase-IV Activity and/or Structure Homologues (DASH) [e.g. DPP2, DPP8 and DPP9] and non-DASH [eg. post-proline cleaving enzyme (PPCE), neutral endopeptidase (NEP), aminopeptidase P (APP), aminopeptidase N (APN)] enzymes.

• Princen Panier specifically address the issue of ACE

  2025-03-03

  

  Princen, 2012, Panier, 2013 specifically address the issue of ACE using the commercial database AMADEUS. However, both studies focus only on corporate leverage and the ACE in Belgium. Due to the lack of a counterfactual, these authors consider firms in other European countries, e.g., France, as a co

• br Materials and methods br

  2025-03-03

  

  Materials and methods Results Discussion The brain is endowed with the 5-LOX enzymatic system (Lammers et al., 1996, Lindgren et al., 1984), but its physiological and pathological roles are still not clear. Inflammation is a characteristic of many neurodegenerative diseases such as Alzheime

• Dryocrassin ABBA The anorexic effect observed when AR is inf

  2025-03-03

  

  The anorexic effect observed when AR231630 is infused into the VTA could be the result of the DA release inhibition, as previously described [11]. However, there is also a hedonic aspect in feeding that possibly involves dopaminergic mechanisms of reward. Helm et al. showed a functional link between

• IC261 australia Drug resistance development often involves

  2025-03-03

  

  Drug resistance development often involves structurally un-related drugs and, specifically both conventional and targeted agents. IGROV-1/Pt1 IC261 australia are characterized by resistance to cisplatin and reduced sensitivity to inhibitors of EGF-R and MEK, the up-stream activator of ERK1/2, assoc

16076 records 1/1072 page Next 12345 下5页 Last page